GGrantIndex
Sort

78,016 grants matching breast cancer

Cognitive Functioning After Breast Cancer Treatment

$464,969
Patricia A. Ganz · University Of California Los Angeles · R01 · FY2008 · CA

Pharmacological Blockage of XBP-1s Expression in Cancer

$464,966
Juan R Del Valle · University Of Notre Dame · R01 · FY2019 · CA

Mechanical Drugs: Harnessing Cancer Aggressiveness to Overcome Its Resistance

$464,964
Dmitri Lapotko · Masimo Corporation · U01 · FY2017 · CA

Biopsychosocial predictors of tumor-associated inflammation and progression

$464,960
Eida Maria Castro · Ponce School Of Medicine · U54 · FY2019 · MD

Dietary Methyl Content, Epigenetics and Breast Cancer

$464,927
Jia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · CA

Mechanism of Intratumoral Transport of Particulate Drugs

$464,910
Haifa Shen · Methodist Hospital Research Institute · R01 · FY2020 · CA

Integrated 3D Xray and Dynamic Tomographic Optical Breast Imaging System

$464,903
David A Boas · Massachusetts General Hospital · R01 · FY2014 · CA

Deguelin in therapy of triple negative breast cancer

$464,897
Rajendra G Mehta · Iit Research Institute · R01 · FY2011 · CA

Mechanisms of Metastasis and Evasion of TGF-Beta Tumor Suppression Breast Cancer

$464,871
Joan Massague · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA

Therapeutic Targeting of Breast Cancer Tumor Initiating Cells

$464,834
Jeffrey Rosen · Baylor College Of Medicine · R01 · FY2010 · CA

CHARACTERIZATION OF RECURRENT ESR1-CCDC170 GENE FUSION IN INVASIVE BREAST CANCER

$464,823
Baylor College Of Medicine · · FY2013 · Department of the Army

Molecular Targets for Cancer Detection and Treatment

$464,808
Johns Hopkins University · T32 · FY2004 · CA

Tumor maintenance and development in mouse models

$464,773
Harold E Varmus · Sloan-Kettering Inst Can Research · U01 · FY2008 · CA

Characterizing Mitochondrial DNA Susceptibility to Breast, Colorectal, and Prosta

$464,757
Iona C Cheng · University Of Hawaii At Manoa · R01 · FY2010 · CA

Role of BMP and FGF signaling during limb development

$464,718
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

The Role of Fgf Signaling in Vertebrate Development

$464,718
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Targeting Autophagy in Hereditary Breast Cancer

$464,713
Bing Xia · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA

Collagen structural changes as an early biomarker for breast carcinoma

$464,700
Matthew W Conklin · University Of Wisconsin-Madison · R01 · FY2016 · CA

TRIM37 is a genetic determinant of racial disparity in metastatic TNBC patients

$464,680
Sanchita Bhatnagar · University Of California At Davis · R01 · FY2022 · CA

Racial Differences in BRCA1/2 Testing: Patients or Providers?

$464,663
Katrina Armstrong · University Of Pennsylvania · R01 · FY2012 · CA

Microchannel cell-based assays to enable cancer research

$464,657
David J Beebe · University Of Wisconsin-Madison · R33 · FY2011 · CA

An innovative integrated computational framework using gene signatures for patient stratification

$464,640
Chao Cheng · Baylor College Of Medicine · R01 · FY2023 · CA

F-Box Proteins: Deregulated Cell Cycle Control and Proteolysis in Cancer

$464,613
Michele Pagano · New York University School Of Medicine · R01 · FY2020 · CA

F-Box Proteins: Deregulated Cell Cycle Control and Proteolysis in Cancer

$464,613
Michele Pagano · New York University School Of Medicine · R01 · FY2017 · CA

F-Box Proteins: Deregulated Cell Cycle Control and Proteolysis in Cancer

$464,613
Michele Pagano · New York University School Of Medicine · R01 · FY2021 · CA